Stress Echocardiography to Detect Exercise Pulmonary Hypertension in Patients With Chronic Thromboembolic Pulmonary Disease
Pulmonary Medicine · 2026
DOI: 10.1155/pm/4127338 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Pulmonary Medicine, 2026. Verfasst von Adam Dhayyat und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Østfold Hospital, Kalnes, Norway. Hauptthemen laut MEDLINE: Echocardiography, Stress, Hypertension, Pulmonary, Pulmonary Embolism. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Helse Sør-Øst RHF, Sykehuset Østfold.
Abstract (Originalsprache)
Background
This study was aimed at determining whether stress echocardiography could detect exercise pulmonary hypertension (ePH) in patients with mild chronic thromboembolic pulmonary disease (CTEPD) as compared with right‐heart catheterization (RHC).
Methods
Thirty‐six symptomatic patients with persistent residual perfusion defects detected using ventilation/perfusion scintigraphy underwent a haemodynamic assessment by RHC and echocardiography at rest and during exercise. We compared pulmonary pressures in echocardiography with RHC values using the definitions in current ESC/ERS guidelines for ePH [mean pulmonary artery pressure/cardiac output (mPAP/CO) slope > 3 mmHg/L/min] and PH (mPAP > 20 mmHg).
Results
Ten of the 36 patients (28%) exhibited an increase in the invasive mPAP/CO slope of > 3 mmHg/L/min. The correlation between echocardiographic and invasive measures of the mPAP/CO slope and systolic pulmonary pressure (sPAP) during peak exercise was ρ = 0.75 (95 % C I = 0.53–0.97) and ρ = 0.75 (95 % C I = 0.53–0.96), respectively. In bivariate logistic regression analyses, ePH was associated with the echocardiographic sPAP during peak exercise [ o d d s r a t i o ( OR ) = 1.13, 95 % C I = 1.02–1.24] and with the echocardiographic mPAP/CO slope ( OR = 3.86, 95 % C I = 1.24–12.03). In ROC analysis, AUC was 0.89 (95 % C I = 0.78–1.00) for the optimal exercise sPAP cut‐off value of 56 mmHg ( s e n s i t i v i t y = 90 % , s p e c i f i c i t y = 87 % ), and 0.84 (95 % C I = 0.66–1.00) for the optimal mPAP/CO slope cut‐off value of 3.7 mmHg/L/min ( s e n s i t i v i t y = 89 % , s p e c i f i c i t y = 79 % ).
Conclusion
Stress echocardiographic assessments of the exercise sPAP and mPAP/CO slope predicted ePH as measured using RHC with good discrimination and acceptable calibration, providing promising evidence in diagnosing ePH in patients with CTEPD. Trial Registration ClinicalTrials.gov identifier: NCT03405480
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Østfold Hospital, Kalnes, Norway.
- Institute of Clinical Medicine, University of Oslo, Oslo, Norway, uio.no.
- Department of Pulmonary Medicine, Akershus University Hospital, Lørenskog, Norway, ahus.no.
- Health Services Research Unit, Akershus University Hospital, Lørenskog, Norway, ahus.no.
- Department of Cardiology, Akershus University Hospital, Lørenskog, Norway, ahus.no.
- Department of Radiology, Østfold Hospital, Kalnes, Norway.
ORCID-Profile: Adam Dhayyat
Förderung
- Helse Sør-Øst RHF
- Sykehuset Østfold
Zitieren
APA
Dhayyat, A., Stavem, K., Jervan, Ø., Hilde, J. M., Rashid, D., Gleditsch, J., Ghanima, W., & Steine, K. (2026). Stress Echocardiography to Detect Exercise Pulmonary Hypertension in Patients With Chronic Thromboembolic Pulmonary Disease. Pulmonary Medicine. https://doi.org/10.1155/pm/4127338
Vancouver
Dhayyat A, Stavem K, Jervan Ø, Hilde JM, Rashid D, Gleditsch J, et al. Stress Echocardiography to Detect Exercise Pulmonary Hypertension in Patients With Chronic Thromboembolic Pulmonary Disease. Pulmonary Medicine. 2026. doi:10.1155/pm/4127338
BibTeX
@article{Dhayyat2026,
author = {Dhayyat, Adam and Stavem, Knut and Jervan, Øyvind and Hilde, Janne Mykland and Rashid, Diyar and Gleditsch, Jostein and Ghanima, Waleed and Steine, Kjetil},
title = {Stress Echocardiography to Detect Exercise Pulmonary Hypertension in Patients With Chronic Thromboembolic Pulmonary Disease},
journal = {Pulmonary Medicine},
year = {2026},
doi = {10.1155/pm/4127338}
}
EUVIMED